Facci, L <br/><br/>
Corticotropin-releasing factor (CRF) and related peptides confer neuroprotection via type 1 CRF receptors.  [electronic resource] 

 -  Neuropharmacology  Oct 2003 
 - 623-36 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>0028-3908 
<br/><br/><label>Standard No.: </label>10.1016/s0028-3908(03)00211-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>1-Methyl-3-isobutylxanthine--pharmacology<br/>Amphibian Proteins<br/>Amyloid beta-Peptides--pharmacology<br/>Animals<br/>Animals, Newborn<br/>Apoptosis<br/>Blotting, Western--methods<br/>Cell Survival--drug effects<br/>Cells, Cultured<br/>Cerebellum<br/>Cerebral Cortex--drug effects<br/>Chromatin--metabolism<br/>Chromones--pharmacology<br/>Colforsin--pharmacology<br/>Corticotropin-Releasing Hormone--antagonists & inhibitors<br/>Cyclic AMP--analogs & derivatives<br/>Dose-Response Relationship, Drug<br/>Drug Interactions<br/>Enzyme Inhibitors--pharmacology<br/>Enzyme-Linked Immunosorbent Assay--methods<br/>Glycogen Synthase Kinase 3--metabolism<br/>Hippocampus--drug effects<br/>In Situ Nick-End Labeling--methods<br/>Inhibitory Concentration 50<br/>L-Lactate Dehydrogenase--metabolism<br/>Mitogen-Activated Protein Kinase Kinases--metabolism<br/>Morpholines--pharmacology<br/>Neurons--drug effects<br/>Neuroprotective Agents--pharmacology<br/>Peptide Fragments--pharmacology<br/>Peptide Hormones<br/>Peptides--pharmacology<br/>Phosphorylation--drug effects<br/>Protein Serine-Threonine Kinases<br/>Proto-Oncogene Proteins--metabolism<br/>Proto-Oncogene Proteins c-akt<br/>Pyrimidines--pharmacology<br/>Pyrroles--pharmacology<br/>Rats<br/>Rats, Sprague-Dawley<br/>Receptors, Corticotropin-Releasing Hormone--metabolism<br/>Thionucleotides--pharmacology<br/>Time Factors<br/>Urocortins<br/>Urotensins--pharmacology<br/>Vasodilator Agents--pharmacology<br/>CRF Receptor, Type 1